Finance

Lists
Why is TGTX up 3,81%?
Dive Deeper
TGTX:NASDAQ
TG Therapeutics Inc common stock
55,37 $
+3,81%
(+2,03) 1D
55,05 $
-0,58% (-0,32)
After hours
Closed: 9 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TGTX...
Open
53,72 $
High
55,46 $
Low
53,36 $
Mkt. cap
8,48 մլրդ
Avg. vol.
1,80 մլն
Volume
1,62 մլն
P/E ratio
20,17
52-wk high
59,30 $
52-wk low
26,76 $
EPS
2,75 $
Beta
1,80
Shares outstanding
153,07 մլն
No. of employees
399
Open
53,72 $
High
55,46 $
Low
53,36 $
Mkt. cap
8,48 մլրդ
Avg. vol.
1,80 մլն
Volume
1,62 մլն
P/E ratio
20,17
52-wk high
59,30 $
52-wk low
26,76 $
EPS
2,75 $
Beta
1,80
Shares outstanding
153,07 մլն
No. of employees
399
News stories
From web sources and news partners
About TG Therapeutics Inc common stock
CEOMichael S Weiss
Employees399
Founded1993
HeadquartersMorrisville, Հյուսիսային Կարոլինա, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 6 analysts giving stock ratings to TGTX in the past 3 months
Buy
Buy
5
Hold
0
Sell
1
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for TGTX in the last 3 months.
Highest
Current 55,37 $
86,00 $ (+55,32%)
Average
69,17 $ (+24,92%)
Lowest
21,00 $ (-62,07%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Maintained
78,00 $
+40,9%
09/21/2026
William Wood
B. Riley Securities
Buy
Maintained
86,00 $
+55,3%
09/02/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
86,00 $
+55,3%
09/02/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
72,00 $
+30%
08/10/2026
Alec Stranahan
Bank of America Securities
Sell
Reiterated
21,00 $
-62,1%
08/05/2026
Tara Bancroft
TD Cowen
Buy
Maintained
75,00 $
+35,5%
08/03/2026
Roger Song
Jefferies
Buy
Maintained
83,00 $
+49,9%
07/14/2026
Unknown Analyst
Jefferies
Buy
Maintained
83,00 $
+49,9%
06/22/2026
Unknown Analyst
B. Riley Securities
Buy
Reiterated
55,00 $
-0,7%
06/03/2026
Corinne Johnson
Goldman Sachs
Hold
Maintained
41,00 $
-26%
06/03/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
161,71 մլն
192,57 մլն
204,92 մլն
240,34 մլն
Cost of goods sold
28,09 մլն
38,14 մլն
33,51 մլն
41,19 մլն
Cost of revenue
28,09 մլն
38,14 մլն
33,51 մլն
41,19 մլն
Research and development expenses
40,88 մլն
41,19 մլն
48,40 մլն
95,34 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
63,37 մլն
62,74 մլն
88,22 մլն
82,13 մլն
Operating expense
104,25 մլն
103,94 մլն
136,61 մլն
177,47 մլն
Total operating expenses
132,34 մլն
142,08 մլն
170,12 մլն
218,66 մլն
Operating income
29,36 մլն
50,49 մլն
34,80 մլն
21,67 մլն
Other non operating income
3,26 մլն
1,13 մլն
2,39 մլն
5,13 մլն
EBT including unusual items
25,91 մլն
45,09 մլն
20,36 մլն
10,23 մլն
EBT excluding unusual items
25,91 մլն
45,09 մլն
29,52 մլն
10,23 մլն
Income tax expense
-364,99 մլն
22,06 մլն
586,00 հզր
2,45 մլն
Effective tax rate
-1 408,72%
48,91%
2,88%
23,97%
Other operating expenses
-
-
-
-
Net income
390,90 մլն
23,04 մլն
19,78 մլն
7,78 մլն
Net profit margin
241,73%
11,96%
9,65%
3,24%
Earnings per share
0,16
0,14
0,18
0,05
Interest and investment income
-
-
-
-
Interest expense
-6,72 մլն
-6,53 մլն
-7,67 մլն
-16,57 մլն
Net interest expenses
-6,72 մլն
-6,53 մլն
-7,67 մլն
-16,57 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
29,38 մլն
50,52 մլն
34,83 մլն
21,73 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps